Write For Us

EU backs J&J booster; GSK/Sanofi shot delayed

Sponsored Post Vitamin D2 Canada Persia
55 Views
Published
EU regulators on Wednesday recommended Johnson & Johnson's shot for use as a booster dose. However, Sanofi and GlaxoSmithKline said they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first quarter, instead of this year, another delay for the potential shot.

#COVID19 #Omicron #Johnson&Johnson #GSK #Sanofi #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, business, finance
Sign in or sign up to post comments.
Be the first to comment